Clinical and Molecular Hepatology (CMH) is a highly regarded journal dedicated to advancing the knowledge of liver diseases and promoting research in hepatology. With an impressive impact factor of 14.0, CMH publishes original articles, reviews, case reports, and editorials covering a comprehensive range of topics related to liver health. The journal addresses critical areas including acute liver injury, cirrhosis, alcoholic and autoimmune liver diseases, metabolic disorders, and liver transplantation.

CMH emphasizes open access, ensuring that vital research findings are readily accessible to healthcare professionals and researchers worldwide. The journal also actively engages with contributors through a detailed peer review process, providing a platform for innovative studies and discussions on liver health challenges.

By keeping readers updated with the latest advancements, including treatment methodologies and epidemiology, CMH plays a pivotal role in the global hepatology community. It serves as an essential resource for those aiming to deepen their understanding and improve outcomes in liver disease management.